I G Ron
Overview
Explore the profile of I G Ron including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klein M, Lotem M, Peretz T, Zwas S, Mizrachi S, Liberman Y, et al.
J Skin Cancer
. 2013 Feb;
2013:828329.
PMID: 23365757
There is a need for effective "broad spectrum" therapies for metastatic melanoma which would be suitable for all patients. The objectives of Phase Ia/Ib studies were to evaluate the safety,...
2.
Asna N, Lewy H, Ashkenazi I, Deutsch V, Peretz H, Inbar M, et al.
Life Sci
. 2005 Feb;
76(16):1825-34.
PMID: 15698860
Efficacy of chemotherapy may be maximized and its toxicity can be minimized if drugs would be administered at specified daily times. The present study was aimed to examine if the...
3.
Sarid D, Ron I, Avinoach I, Sperber F, Inbar M
Am J Clin Oncol
. 2002 Aug;
25(4):380-2.
PMID: 12151969
Spontaneous regression of pure seminoma metastases is a rare phenomenon, with only a few cases reported to date. To the best of our knowledge, this is the first report of...
4.
Ron I, Soyfer V, Goldray D, Inbar M, Weisman Y
Eur J Cancer
. 2002 Jul;
38(11):1490-4.
PMID: 12110495
Megestrol acetate (MA) has glucocorticoid activity and can induce significant secondary adrenal suppression. We designed this study to determine the extent of adrenal insufficiency in cancer patients receiving MA by...
5.
Ron I, Kovner F, Lifschitz-Mercer B, Inbar M
Acta Oncol
. 2001 Oct;
40(5):629-32.
PMID: 11669336
Disagreement persists on the necessity of axillary lymph node dissection for small T1 stage unilateral breast cancers. In this study of 120 women with T1 primary tumors who underwent extensive...
6.
Ron I, Wigler N, Borovik R, Brufman G, Rizel S, Shani A, et al.
Am J Clin Oncol
. 2001 Jul;
24(4):323-7.
PMID: 11474254
A multicenter phase III randomized study compared the efficacies of two adjuvant polychemotherapeutic regimens in 145 patients with stage II node-positive breast cancer. The standard chemotherapy combination, CMF (cyclophosphamide, methotrexate,...
7.
Fait G, Kupferminc M, Daniel Y, Geva E, Ron I, Lessing J, et al.
Gynecol Oncol
. 2000 Nov;
79(2):177-80.
PMID: 11063640
Objective: The purpose of this work was to evaluate the ability of testing for high-risk human papillomavirus (HPV) types using the hybrid capture technique to predict the presence of cervical...
8.
Bar-Am A, Daniel Y, Ron I, Niv J, Kupferminc M, Bornstein J, et al.
Gynecol Oncol
. 2000 Jun;
78(1):47-51.
PMID: 10873409
Objectives: Loop electrosurgical excision of the transformation zone (LEETZ) was recently associated with relatively high failure rates. We evaluated whether the combination of LEETZ with laser vaporization is superior to...
9.
Fata F, Ron I, Maluf F, Klimstra D, Kemeny N
Cancer
. 2000 Jun;
88(11):2447-51.
PMID: 10861419
Background: Intra-abdominal and retroperitoneal fibrosis has been described as secondary to intraperitoneal (IP) administration of several chemotherapeutic agents, including carboplatin, mitoxantrone, and the combination of 5-fluorouracil and cisplatin. The IP...
10.
Ron I, Ron H, Lerman Y
Int J Occup Environ Health
. 2000 Jan;
5(4):304-6.
PMID: 10633249
Three cases of fatal extrapulmonary neoplasms among asbestos-exposed power plant workers are described. These cases add to the growing evidence for a causal relationship between asbestos exposures and extrapulmonary neoplasms.